Literature DB >> 11587182

Eye involvement in hyperimmunoglobulinemia E (Job's) syndrome.

M Orhan1, Y Ozkan, M Irkeç.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11587182     DOI： 10.3928/0191-3913-20010901-14

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN： 0191-3913            Impact factor:   1.402


× No keyword cloud information.
  6 in total

1.  Recurrent giant chalazia in hyperimmunoglobulin E (Job's) syndrome.

Authors:  Pierpaolo Patteri; Alain Serru; Maria Letizia Chessa; Michele Loi; Antonio Pinna
Journal:  Int Ophthalmol       Date:  2008-06-05       Impact factor: 2.031

2.  Psoriasis in hyper IgE syndrome - a case report.

Authors:  Javad Ghaffari; Saeed Abedian-Kenari; Maryam Ghasemi; Farzad Gohardehi
Journal:  Caspian J Intern Med       Date:  2013

Review 3.  STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

Authors:  Christo Tsilifis; Alexandra F Freeman; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2021-05-01       Impact factor: 8.317

Review 4.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

Review 5.  Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities.

Authors:  Hassan Hashemi; Masoumeh Mohebbi; Shiva Mehravaran; Mehdi Mazloumi; Hamidreza Jahanbani-Ardakani; Seyed-Hossein Abtahi
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852

6.  Ophthalmic complications including retinal detachment in hyperimmunoglobulinemia E (Job's) syndrome: Case report and review of literature.

Authors:  Vipul Arora; Usha R Kim; Hadi M Khazei; Shivayogi Kusagur
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.